XML 62 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1
Organization Organization Text Tag (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Dec. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Mar. 31, 2003
Sep. 17, 2003
Oct. 24, 1994
Cash and due from banks $ 58,428       $ 62,684 [1],[2]         $ 58,428 $ 62,684 [1],[2]        
Total loans receivable, net 540,492       583,396 [1],[3]         540,492 583,396 [1],[3]        
Other assets 5,829       7,032 [1]         5,829 7,032 [1]        
Other                   8,899 8,744 [2],[4]        
Total cash and cash equivalents 58,686       63,188 [1],[5],[6],[7]         58,686 63,188 [1],[5],[6],[7] $ 50,824 [5],[6]      
Accrued interest receivable 1,583       2,420 [1]         1,583 2,420 [1]        
Loans held-for-sale (HFS) 944       2,436 [1],[8]         944 2,436 [1],[8]        
Increase (Decrease) in Loans, Deferred Income                   (57) (136) [5],[6]        
Increase (Decrease) in Accrued Interest Receivable, Net                   (837) (76) [5],[6]        
Accrued interest expense subordinated debt 315       2,300         315 2,300        
Advances and other borrowed money                   1,257 1,336 [2],[9]        
Loan fees and service charges                   407 419 [2],[5]        
Accumulated deficit (50,898)       (48,045) [2],[5]         (50,898) (48,045) [2],[5]        
Other liabilities 11,884       12,030 [1],[2]         11,884 12,030 [1],[2]        
Restatement Adjustment (1)                       (738)      
Net loss $ (2,034) $ (893) $ (251) $ 325 $ (1,489) $ 156 $ (563) $ 129   $ (2,853) $ (1,767) [2],[5],[6]        
Loss Per Share, Basic (in dollars per share) $ (0.55) $ (0.24) $ (0.07) $ 0.04 $ (0.40) $ 0.02 $ (0.15) $ 0.01   $ (0.77) $ (0.48) [2]        
Common Stock, Shares Issued (in shares) 3,698,031       3,698,031         3,698,031 3,698,031       2,314,375
Common Stock, Par Value (in dollars per share) $ 0.01       $ 0.01         $ 0.01 $ 0.01       $ 0.01
subordinated debt issued shares (in shares)                           13,000  
Liquidation amount subordinated debt (in dollars per share)                           $ 1,000  
Proceeds from Issuance of Long-term Debt                         $ 13,000    
Proceeds from (Payments for) Other Financing Activities                         400    
Payments for Repurchase of Trust Preferred Securities                         $ 13,400    
Debt Instrument, Basis Spread on Variable Rate                   3.05%          
Quantifying Misstatement in Current Year Financial Statements, Amount $ 1,700                 $ 1,000 $ 666 361      
Restatement of Prior Year Income, Gross                   $ 1,200 865 285      
Restatement Adjustment                              
Cash and due from banks         $ (472)           (472)        
Total loans receivable, net         (391)           (391)        
Other assets         (525)           (525)        
Other Liabilities, Noncurrent         497           497        
Other                     666        
Total cash and cash equivalents         (472)           (472) (168)      
Increase (Decrease) in Other Operating Assets and Liabilities, Net                     362        
Accrued interest receivable         (1,227)           (1,227)        
Loans held-for-sale (HFS)         (59)           (59)        
Increase (Decrease) in Loans, Deferred Income                     (52)        
Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net                     25        
Increase (Decrease) in Accrued Interest Receivable, Net                     942        
Accrued interest expense subordinated debt         158           158 $ 92      
Advances and other borrowed money                     66        
Loan fees and service charges                 $ 78   (521)        
Accumulated deficit         (2,335)           (2,335)        
Other liabilities         (339)           (339)        
Net loss   $ 263 $ 1 $ (83) $ (460) $ (414) $ (407) $ (316)     $ (1,597)        
Loss Per Share, Basic (in dollars per share)   $ 0.07 $ 0.00 $ 0.00 $ (0.12) $ (0.04) $ (0.11) $ (0.04)     $ (0.43)        
[1] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Equity in net loss from subsidiaries was increased and total income was reduced by $1.5 million, interest expense on borrowings and total expense were increased by $66 thousand, and net loss and comprehensive loss were increased $1.6 million. Refer to Notes 1 and 19 for further detail.
[2] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.
[3] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.
[4] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.
[5] (1) March 31, 2015 and 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.
[6] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Net loss was increased by $1.6 million, equity in net loss of subsidiaries was increased by $1.5 million and increase in other liabilities was increased by $66 thousand. Refer to Notes 1 and 19 for further detail.
[7] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.
[8] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Investment in subsidiaries, total assets and total liabilities and stockholders' equity were each reduced by $2.2 million, other liabilities and total liabilities increased by $157 thousand and stockholders' equity was reduced by $2.3 million. Refer to Notes 1 and 19 for further detail.
[9] (a) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.